Discover more: https://bit.ly/4d3W4tt
Phase 3 FUSION results suggest a targeted therapy may slow disease progression in FUS-ALS, with benefits seen versus placebo.
@alsnewstoday.bsky.social
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/4d3W4tt
Phase 3 FUSION results suggest a targeted therapy may slow disease progression in FUS-ALS, with benefits seen versus placebo.
@alsnewstoday.bsky.socialThe impact you’ve had on people is woven into their lives in lasting ways.
#ALSCommunity
@alsnewstoday.bsky.socialGet the scoop: https://bit.ly/4xNkXRH
ALS disrupted her relationship with her body, so columnist Dagmar Munn developed small, intentional habits to restore her confidence.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/3VMK4qj
Mouse model study finds molecular changes in inflammation, RNA, and protein processing before ALS symptoms appear.
@alsnewstoday.bsky.socialExplore the details: https://bit.ly/4cXwy9l
ALS may change what marriage looks like for guest columnist Nancy Muirhead and her husband, but it cannot change their love.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/4Aokzvz
Researchers identified changes in 10 genes that may help diagnose or track ALS, according to a computer analysis of thousands of genes.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/4ApNKyi
The first healthy participant has been dosed in a Phase 1 clinical trial of ACE-2223, an experimental treatment for ALS.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/4y2rith
Geneuro received a European patent for GNK-301, an ALS therapy candidate targeting a viral protein thought to contribute to the disease.
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/46xm50F
A brain-computer interface enabled a woman with a motor neuron disease to generate her own words in real time, according to its developer.
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/4jaBz20
Columnist Kristin Neva pauses to reflect on the uncertainty of living with ALS, even as she commits to making memories with her husband.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/3TCmdcf
Keynote speaker Mindy Henderson redefines "impossible" ahead of MDA Engage: Chicago, taking place Sept. 25-26 at the Westin Chicago Lombard.
@alsnewstoday.bsky.socialGet the scoop: https://bit.ly/4AiSiX1
A fitness routine columnist Dagmar Munn developed for a wellness project became a core part of her own exercise regimen after her diagnosis.
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/4heYC9u
The 100th participant has been enrolled in a Phase 2/3 clinical trial testing COYA 302, Coya Therapeutics’ experimental therapy for ALS.
@alsnewstoday.bsky.socialGet the scoop: https://bit.ly/4xYhTD7
Five Canadian students personally affected by ALS each received $2,500 from ALS Canada's Kevin Daly Bursary.
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/4dIiC39
A filmmaker with amyotrophic lateral sclerosis (ALS) is working with his friends to finish a documentary about death.
@alsnewstoday.bsky.socialStrength can exist without movement, effort, or action.
#ALScommunity
@alsnewstoday.bsky.socialGet the scoop: https://bit.ly/4A9QHCM
Patients' personal preferences and not disease severity were linked to requests for medically assisted death in people with ALS in a study.
@alsnewstoday.bsky.socialToday holds space for you exactly as you are.
#ALSCommunity
@alsnewstoday.bsky.socialTake a closer look: https://bit.ly/46fNd4f
Columnist Juliet Taylor shares what she wishes she'd known about the emotional weight of being a caregiver before ALS entered the picture.
@alsnewstoday.bsky.socialDiscover more: https://bit.ly/4xPh1R6
Columnist Kristin Neva has lived for 16 years with grief and stress, but here writes about finding moments that push ALS into the background.